We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

133 hedge funds and large institutions have $633M invested in Taro Pharmaceutical Industries Ltd. in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 46 increasing their positions, 41 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 41

5% less funds holding

Funds holding: 140 → 133 (-7)

6% less capital invested

Capital invested by funds: $671M → $633M (-$38.2M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

47% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 15

99% less call options, than puts

Call options by funds: $36K | Put options by funds: $2.43M

Holders
133
Holders Change
-7
Holders Change %
-5%
% of All Funds
3.32%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
8
Increased
46
Reduced
41
Closed
15
Calls
$36K
Puts
$2.43M
Net Calls
-$2.4M
Net Calls Change
-$1.23M

Top Buyers

1
AL
AJO LP
Pennsylvania
+$18.1M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.05M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.78M
4
BIP
Brandes Investment Partners
California
+$2.38M
5
Goldman Sachs
Goldman Sachs
New York
+$2.11M

Top Sellers

1
CG
Carmignac Gestion
France
-$16.5M
2
MICM
Matthews International Capital Management
California
-$16.5M
3
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$12.9M
4
RRAM
River Road Asset Management
Kentucky
-$7.34M
5
AAF
Andra AP-fonden
Sweden
-$4.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
Public Employees Retirement Association of Colorado
76
Public Employees Retirement Association of Colorado
Colorado
$563K -$141K -1,300 -21%
Citigroup
77
Citigroup
New York
$517K -$385K -3,541 -44%
IPAM
78
ICICI Prudential Asset Management
India
$451K -$54.4K -500 -11%
Zurich Cantonal Bank
79
Zurich Cantonal Bank
Switzerland
$442K – – –
HAM
80
Highstreet Asset Management
Ontario, Canada
$408K +$157K +1,441 +66%
BCIM
81
British Columbia Investment Management
British Columbia, Canada
$383K +$174K +1,600 +89%
TD Asset Management
82
TD Asset Management
Ontario, Canada
$372K – – –
ASN
83
Advisory Services Network
Georgia
$344K -$264K -2,422 -44%
NFA
84
Nationwide Fund Advisors
Ohio
$324K – – –
HSBC Holdings
85
HSBC Holdings
United Kingdom
$308K -$43.9K -403 -13%
LCM
86
Landscape Capital Management
New Jersey
$308K +$297K +2,734 New
Comerica Bank
87
Comerica Bank
Texas
$276K – – –
WAM
88
World Asset Management
Michigan
$271K -$1.2K -11 -0.5%
GH
89
GAM Holding
Switzerland
$270K – – –
QI
90
QS Investors
New York
$259K +$76.2K +700 +44%
Russell Investments Group
91
Russell Investments Group
United Kingdom
$254K – – –
State Board of Administration of Florida Retirement System
92
State Board of Administration of Florida Retirement System
Florida
$245K +$21.8K +200 +10%
Bank of Montreal
93
Bank of Montreal
Ontario, Canada
$242K +$2.07K +19 +0.9%
EM
94
ELCO Management
New York
$240K – – –
Bessemer Group
95
Bessemer Group
New Jersey
$237K +$2.18K +20 +1%
Prudential Financial
96
Prudential Financial
New Jersey
$236K -$33.6K -309 -13%
ANI
97
American National Insurance
Texas
$234K – – –
Wells Fargo
98
Wells Fargo
California
$196K +$5.22K +48 +3%
BNP Paribas Financial Markets
99
BNP Paribas Financial Markets
France
$196K -$448K -4,117 -70%
AIG
100
American International Group
New York
$182K +$9.14K +84 +5%
2 3
4
5 6

TARO Hedge Fund Activity: Q3 2017 in Review

133 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q3 2017, worth a combined $633M — down 5.7% from $671M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of TARO and 8 opened new positions — a net loss of 7 holders — while 41 trimmed existing stakes and 46 added.

The largest buyer was AJO LP, adding an estimated $18.1M. The largest seller was Carmignac Gestion, exiting entirely with an estimated $16.5M sold.

  • 133 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q3 2017, down from 140 in Q2 2017.
  • Funds reported $633M of Taro Pharmaceutical Industries Ltd. stock for Q3 2017, down 5.7% quarter-over-quarter.
  • 8 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q3 2017 and 15 closed out, a net change of -7 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q3 2017 was AJO LP, an estimated $18.1M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q3 2017 was Carmignac Gestion, an estimated $16.5M sold.

Based on aggregated 13F filings for Q3 2017.